Network origin in Randy Fawcett first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Randy Fawcett via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Chief Executive Officer Director/Board Member | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal General Counsel | ||
| NUVATION BIO INC. | Biotechnology | Chairman Director/Board Member | |
Prothena Biosciences, Inc.
 Prothena Biosciences, Inc. BiotechnologyHealth Technology Part of Prothena Corp. Plc, Prothena Biosciences, Inc. is a company that specializes in the biology of misfolded proteins. The company is based in South San Francisco, CA. The company has over 3 decades of expertise in this field and offer a range of services including science, pipeline, clinical trial information, and more. | Biotechnology | Director/Board Member Chairman | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Schwartz Pharma AG
 Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman | |
| CODEMILL AB | Packaged Software | Comptroller/Controller/Auditor | |
| Pharmacia GmbH | Private Equity Investor | ||
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member | |
| Georgetown University | College/University | Undergraduate Degree | |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Investment Managers | Chief Executive Officer | |
| EcoR1 Panacea Holdings LLC | Chief Executive Officer | ||
| University of Gothenburg | College/University | Doctorate Degree | |
| ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Neotope Biosciences Ltd.
 Neotope Biosciences Ltd. Medical/Nursing ServicesHealth Services Neotope Biosciences Ltd. provides biological research services. The company is headquartered in South San Francisco, CA. | Medical/Nursing Services | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University College Dublin | College/University | Graduate Degree | |
| ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member | |
Pembroke Capital Ltd.
 Pembroke Capital Ltd. Finance/Rental/LeasingFinance Part of Standard Chartered Plc, Pembroke Capital Ltd. is an Irish company that specializes in tax benefits and investment risks related to venture capital trusts. The company is based in Dublin, Ireland. The company offers significant tax advantages over most investment products, particularly in new VCT shares, with tax reliefs available on investment including income tax relief of up to 30%%. Pembroke Capital was founded by Margaret Clandillon and Shane M. Cooke. The CEO is Kieran Corr. | Finance/Rental/Leasing | Chief Executive Officer | |
Prothena Therapeutics Ltd.
 Prothena Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Prothena Corp. Plc, Prothena Therapeutics Ltd. is an Irish nonprofit company located in Dublin that provides business services. | Miscellaneous Commercial Services | Director/Board Member | |
| ENDO INTERNATIONAL PLC | Pharmaceuticals: Major | Director/Board Member | |
Elan Drug Technologies
 Elan Drug Technologies Pharmaceuticals: OtherHealth Technology Part of Perrigo Co. Plc, Elan Drug Technologies is an Irish company that manufactures and distributes drugs. The company is based in Athlone, Ireland. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Alkermes Pharma Ireland Ltd.
 Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Pharmaceuticals: Major | Chairman | |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
| UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Chairman | |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Investment Managers | Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chairman | |
| PANACEA ACQUISITION CORP. II | Financial Conglomerates | Chief Executive Officer | |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | Biotechnology | Director/Board Member | |
Biotechnology Value Fund LP
 Biotechnology Value Fund LP Investment ManagersFinance Part of BVF, Inc., Biotechnology Value Fund LP is an Alternative Investment Manager. The company is based in San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Corporate Officer/Principal | |
| University of Sao Paulo | College/University | Doctorate Degree |
Statistics
International
| United States | 31 |
| Ireland | 11 |
| Switzerland | 4 |
| Germany | 3 |
| Sweden | 3 |
Sectoral
| Health Technology | 31 |
| Finance | 8 |
| Consumer Services | 5 |
| Commercial Services | 4 |
| Health Services | 3 |
Operational
| Director/Board Member | 75 |
| Corporate Officer/Principal | 44 |
| Independent Dir/Board Member | 29 |
| Chairman | 22 |
| Undergraduate Degree | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Helen Kim | 33 |
| Daniel Welch | 24 |
| Lars Ekman | 21 |
| Dennis Selkoe | 16 |
| Oleg Nodelman | 15 |
| Shane Cooke | 13 |
| Tran Nguyen | 10 |
| Hideki Garren | 9 |
| Paula Cobb | 8 |
| Carol Karp | 8 |
| Michael J. Malecek | 8 |
| Karin Walker | 8 |
| Richard Collier | 7 |
| Gene Kinney | 7 |
| Brandon Smith | 6 |
- Stock Market
- Insiders
- Randy Fawcett
- Company connections
